Principal Securities, Inc. Vir Biotechnology, Inc. Transaction History
Principal Securities, Inc.
- $3.63 Trillion
- Q2 2024
A detailed history of Principal Securities, Inc. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 33 shares of VIR stock, worth $267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33Holding current value
$267% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VIR
# of Institutions
233Shares Held
87.6MCall Options Held
231KPut Options Held
132K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$135 Million1.37% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$133 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$104 Million0.0% of portfolio
-
State Street Corp Boston, MA5.09MShares$41.3 Million0.0% of portfolio
-
Baillie Gifford & CO3.92MShares$31.8 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.08B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...